Maternal and Infant Vitamin Status During the First Nine Months of Infant Life

Sponsor
University of Aarhus (Other)
Overall Status
Completed
CT.gov ID
NCT02548520
Collaborator
(none)
107
1
41
2.6

Study Details

Study Description

Brief Summary

In this study the investigators wanted to assess vitamin D status and possible consequences of low plasma 25-hydroxyvitamin D levels in a population of healthy mothers and their infants, in the community of Aarhus, Denmark.

Condition or Disease Intervention/Treatment Phase
  • Other: Blood and breastmilk samples

Detailed Description

Danish people living at northern latitudes (56°N), often with overcast and foggy weather and few sunshine hours are at increased risk of vitamin D insufficiency. Although vitamin D is obtainable from fortified food and oily fish, the major source is the dermal synthesis of the vitamin D through exposure to solar ultraviolet light.

In the 19th century rickets was endemic in northern Europe, and many children developed rickets, a severe bone-deforming disease. Encouragement of sensible sun exposure, supplementation with cod liver oil and fortification of milk with vitamin D, resulted in an almost complete eradication of rickets by the end of the 19th century. At present vitamin D deficiency seems again to be more widespread. The classical outcomes of severe vitamin D deficiency are rickets in growing individuals and osteomalacia in adults. Low vitamin D status also relates to low bone density and increased risk of osteoporotic fractures. Although the incidence of rickets has declined over the last decades, cases attributable to inadequate vitamin D intake and low exposure to sunlight continue to be reported, and maternal vitamin D status may have permanent effects on newborns' health. Pregnant women, newborns, breastfed children, and lactating women are at a high risk of vitamin D deficiency, especially during winter and early spring.

Since fetal plasma 25-hydroxyvitamin D (25OHD) depends on maternal 25OHD, fetal vitamin D status may show seasonal changes parallel to those observed in the mothers. To prevent rickets and vitamin D deficiency in infants, most Western countries, including Denmark, recommend a daily maternal intake during pregnancy and lactation of 10 μg and that breastfed children are given a supplement of 10 μg of vitamin D/day. Despite these recommendations, approximately one third of Danish pregnant and lactating women have vitamin D insufficiency. However, childhood rickets is nowadays rare in Denmark, although it still exists especially among immigrants and mothers with prolonged lactation. Accordingly, in 2010, the Danish National Board of Health extended the recommendations for vitamin D supplementation to the first two years of life.

Study Design

Study Type:
Observational
Actual Enrollment :
107 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Vitamin D Status in the First 9 Months of Life
Study Start Date :
Oct 1, 2008
Actual Primary Completion Date :
Jul 1, 2011
Actual Study Completion Date :
Mar 1, 2012

Outcome Measures

Primary Outcome Measures

  1. Prevalence in plasma 25OHD and parathyroid hormone at birth [at birth (baseline)]

    For determination of plasma 25OHD and plasma parathyroid hormone concentrations, the investigators sampled cord blood at baseline. Furthermore the investigators collected maternal blood at 2 weeks after birth (baseline).

Secondary Outcome Measures

  1. Prevalence in plasma 25OHD and parathyroid hormone at 4 months [at 4 months]

    For determination of plasma 25OHD and plasma parathyroid hormone concentrations, the investigators sampled maternal and infants blood samples at 4 months (1. follow-up).

  2. Prevalence in plasma 25OHD and parathyroid hormone at 9 months [at 9 months]

    For determination of plasma 25OHD and plasma parathyroid hormone concentrations, the investigators sampled maternal and infants blood samples at 9 months (2. follow-up).

Other Outcome Measures

  1. Questionnaire about lifestyle factors at birth [at birth]

    At birth the investigators collected, via self reported focused questionnaires, data regarding breastfeeding status, use of vitamin D supplements among children and their mothers, use of calcium supplements and dietary calcium intake (milk and cheese consumption) and other lifestyle factors, including physical activity (baseline).

  2. Questionnaire about lifestyle factors at 4 months [at 4 months]

    At 4 months the investigators collected, via self reported focused questionnaires, data regarding breastfeeding status, use of vitamin D supplements among children and their mothers, use of calcium supplements and dietary calcium intake (milk and cheese consumption) and other lifestyle factors, including physical activity (1. follow up).

  3. Questionnaire about lifestyle factors at 9 months [at 9 months]

    At 9 months visit the investigators collected, via self reported focused questionnaires, data regarding breastfeeding status, use of vitamin D supplements among children and their mothers, use of calcium supplements and dietary calcium intake (milk and cheese consumption) and other lifestyle factors, including physical activity (2. follow up).

  4. peripheral Quantitative Computed Tomography i nine months old infants [at 9 months]

    At 9 months the investigators investigated 1) whether there was a correlation between maternal vitamin D status or calcium intake (i.e. diet and supplements) and bone mass and structure as measured by peripheral quantitative computed tomography in the infants 9 months after birth, and 2) gender differences in measured peripheral quantitative computed tomography variables. Furthermore the investigators evaluated 3) the feasibility of performing peripheral quantitative computed tomography scans on newborn infants in terms of assessing the precision of peripheral quantitative computed tomography scan.

Eligibility Criteria

Criteria

Ages Eligible for Study:
24 Years to 41 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Healthy pregnant Caucasian women aged 24-41 years,

  • A normal pregnancy giving birth between 38-42 gestational weeks.

Exclusion Criteria:
  • Chronic diseases,

  • Other ethnic origin than Caucasian, and

  • Alcohol or drug abuse.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Department of Internal Medicine and Endocrinology, Aarhus University Hospital Aarhus Central Denmark Region Denmark DK-8000

Sponsors and Collaborators

  • University of Aarhus

Investigators

  • Principal Investigator: Susanna við Streym, PhD, Department of Internal Medicine and Endocrinology, Aarhus University Hospital
  • Study Director: Lars Rejnmark, Professor, Department of Internal Medicine and Endocrinology, Aarhus University Hospital
  • Study Chair: Peter Vestergaard, Professor, The Department of Endocrinology, Aalborg University Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
University of Aarhus
ClinicalTrials.gov Identifier:
NCT02548520
Other Study ID Numbers:
  • M-2007-0255
First Posted:
Sep 14, 2015
Last Update Posted:
Sep 14, 2015
Last Verified:
Sep 1, 2015
Additional relevant MeSH terms:

Study Results

No Results Posted as of Sep 14, 2015